Fosfomycin: A Look at Its Various Aspects

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Fosfomycin: A Look at Its Various Aspects Publisher

Tajik S¹ ; Shokri F² ; Rostamnezhad M³ ; Khoshnood S⁴ ; Mortazavi SM⁴ ; Sholeh M⁵ ; Kouhsari E^{6, 7}

Source: Gene Reports Published:2020

Abstract

Today, due to the emergence and spread of multidrug-resistant bacteria that have caused many therapeutic problems for the medical systems, and the lack of production of effective antibiotics in the commercial field in recent years, physicians are increasingly interested in using older antibiotics such as fosfomycin. Besides, because of the relatively low bacterial resistance to fosfomycin and its broad spectrum of action, it seems to be a molecule of therapeutic interest in the era of infection treatment. This antibiotic is still effective against many multidrug-resistant and extensively drug-resistant bacteria by inhibiting the early stages of the cell wall assembly. In this review, we summarize the currently available data regarding pharmacokinetics and pharmacodynamics, mechanism of action, oral and parenteral use, susceptibility breakpoints, antibacterial activity, mechanisms and epidemiology of resistance, and adverse effects of fosfomycin. © 2020

Related Docs

View other Related Docs

1. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered From Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years, Microbial Drug Resistance (2018)

2. Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (Esbl) Producing Enterobacteriaceae Isolated From Three Centers of Tehran, Iran, Recent Patents on Anti-Infective Drug Discovery (2018)

3. Global Prevalence and Antibiotic Resistance in Clinical Isolates of Stenotrophomonas Maltophilia: A Systematic Review and Meta-Analysis, Frontiers in Medicine (2023)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Boroumand (1)

Hossein Khalili (1)

Other Related Docs

4. Synergistic Antimicrobial Therapy Using Nanoparticles and Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infection, Nano Futures (2017)

5. Mechanism of Action, Resistance, Synergism, and Clinical Implications of Azithromycin, Journal of Clinical Laboratory Analysis (2022)

6. Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas Aeruginosa by Using an Efflux Pump Inhibitor, Infection and Chemotherapy (2015)

7. Bacteria-Derived Chimeric Toxins As Potential Anticancer Agents, Frontiers in Oncology (2022)

8. Design and Synthesis of New N-Thioacylated Ciprofloxacin Derivatives As Urease Inhibitors With Potential Antibacterial Activity, Scientific Reports (2022)

9. Novel Fluoroquinolones Analogues Bearing 4-(Arylcarbamoyl)Benzyl: Design, Synthesis, and Antibacterial Evaluation, Molecular Diversity (2023)

10. The Central Role of the Sos Dna Repair System in Antibiotics Resistance: A New Target for a New Infectious Treatment Strategy, Life Sciences (2020)

11. Bacteriocins: Properties and Potential Use As Antimicrobials, Journal of Clinical Laboratory Analysis (2022)

12. Prevalence of Antibiotic-Resistant Lactobacilli in Sepsis Patients With Long-Term Antibiotic Therapy, Current Microbiology (2022)

13. Frequency of Inducible Clindamycin Resistance and Analysis of Multi-Resistant Antibiotic Profile of Methicillin-Resistant Staphylococcus Aureus, Journal of Mazandaran University of Medical Sciences (2015)

14. Treatment Options for Infections Caused by Multidrug-Resistant Gram-Negative Bacteria: A Guide to Good Clinical Practice, Future Microbiology (2023)

15. Frequency of Inducible Clindamycin Resistance Among Gram-Positive Cocci in a Tertiary Hospital, Tehran, Iran, Iranian Journal of Microbiology (2016)

16. Postbiotic As Novel Alternative Agent or Adjuvant for the Common Antibiotic Utilized in the Food Industry, Current Pharmaceutical Biotechnology (2024)

17. Corrigendum to ‘Successive Cytotoxicity Control by Evolutionary Surface Decorated Electronic Push-Pull Green Zncr-Ldh Nanostructures: Drug Delivery Enlargement for Targeted Breast Cancer Chemotherapy’[Opennano 8 (2022) 100093] (Opennano (2022) 8, (S235295202200055x), (10.1016/J.Onano.2022.100093)), OpenNano (2023)

18. New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria, Frontiers in Microbiology (2017)

19. Changes of Microbial Cell Survival, Metabolic Activity, Efflux Capacity, and Quorum Sensing Ability of Aggregatibacter Actinomycetemcomitans Due to Antimicrobial Photodynamic Therapy-Induced Bystander Effects, Photodiagnosis and Photodynamic Therapy (2019)

20. The Lactobacillus Acidophilus Supernatant: An Effective and Safe Alternative to Antibiotics, Iranian Journal of Toxicology (2024)

Style	Citing Format
MLA	Tajik S, et al.. "Fosfomycin: A Look at Its Various Aspects." Gene Reports, vol. 19, no. , 2020, pp. -.
APA	Tajik S, Shokri F, Rostamnezhad M, Khoshnood S, Mortazavi SM, Sholeh M, Kouhsari E (2020). Fosfomycin: A Look at Its Various Aspects. Gene Reports, 19(), -.
Chicago	Tajik S, Shokri F, Rostamnezhad M, Khoshnood S, Mortazavi SM, Sholeh M, Kouhsari E. "Fosfomycin: A Look at Its Various Aspects." Gene Reports 19, no. (2020): -.
Harvard	Tajik S et al. (2020) 'Fosfomycin: A Look at Its Various Aspects', Gene Reports, 19(), pp. -.
Vancouver	Tajik S, Shokri F, Rostamnezhad M, Khoshnood S, Mortazavi SM, Sholeh M, et al.. Fosfomycin: A Look at Its Various Aspects. Gene Reports. 2020;19():-.
BibTex	@article{ author = {Tajik S and Shokri F and Rostamnezhad M and Khoshnood S and Mortazavi SM and Sholeh M and Kouhsari E}, title = {Fosfomycin: A Look at Its Various Aspects}, journal = {Gene Reports}, volume = {19}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Tajik S AU - Shokri F AU - Rostamnezhad M AU - Khoshnood S AU - Mortazavi SM AU - Sholeh M AU - Kouhsari E TI - Fosfomycin: A Look at Its Various Aspects JO - Gene Reports VL - 19 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract